Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Recruiting 4Active not recruiting 4Completed 3Terminated 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Gynecologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 13Neoplasms 10Melanoma 9Lung Neoplasms 8Breast Neoplasms 8Multiple Myeloma 7Leukemia, Myeloid, Acute 7Prostatic Neoplasms 6Pancreatic Neoplasms 6Ovarian Neoplasms 5Neoplasm Metastasis 5Colorectal Neoplasms 5Brain Neoplasms 5Myelodysplastic Syndromes 4Lymphoma, Non-Hodgkin 4Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4Endometrial Neoplasms 4Uterine Cervical Neoplasms 3Urinary Bladder Neoplasms 3Triple Negative Breast Neoplasms 3Squamous Cell Carcinoma of Head and Neck 3Recurrence 3Rectal Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Lymphoma, Large B-Cell, Diffuse 3Leukemia, Lymphocytic, Chronic, B-Cell 3Hodgkin Disease 3Carcinoma, Transitional Cell 3Carcinoma, Renal Cell 3Thyroid Neoplasms 2

Interventions

Tablets 1Megestrol Acetate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Obesity × 30 days × Clear all
NCT05316467 2026-06-04

Weight Management Plus Megestrol Acetate in Early-stage Endometrioid Carcinoma

Fudan University

Phase 2/3 Terminated
8 enrolled
GynecologicOther

Infertility, Obesity, Endometrial Neoplasms, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon âš¡